Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia
Open Access
- 30 July 2018
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 19 (1) , 132
Abstract
Pseudohypoparathyroidism type 1A (PHP1A) is a rare genetic disease primarily characterized by resistance to parathyroid hormone along with hormonal resistance and other features of Albright hereditary osteodystrophy (AHO). It is caused by heterozygous inactivating mutations in the maternal allele of the GNAS gene, which encodes the stimulatory G-protein alpha subunit (Gsα) and regulates production of the second messenger cyclic AMP (cAMP). Herein, we report a case of of PHP1A with atypical clinical manifestations (oligomenorrhea, subclinical hypothyroidism, and normocalcemia) and explore the underlying genetic cause in this patient. Blood samples were collected from the patient, her family members, and 100 healthy controls. The 13 exons and flanking splice sites of the GNAS gene were amplified by PCR and sequenced. To further assess whether the novel mutation resulted in gain or loss of function of Gsα, we examined the level of cAMP activity associated with this mutation through in vitro functional studies by introducing the target mutation into a human GNAS plasmid. A novel heterozygous c.715A > G (p.N239D) mutation in exon 9 of the GNAS gene was identified in the patient. This mutation was also found in her mother, who was diagnosed with pseudopseudohypoparathyroidism. An in vitro cAMP assay showed a significant decrease in PTH-induced cAMP production in cells transfected with the mutant plasmid, compared to that in the wild-type control cells (P < 0.01), which was consistent with loss of Gsa activity. We identified a novel GNAS mutation that altered Gsα function, which furthers our understanding of the pathogenesis of this disease. Screening for GNAS mutations should be considered in suspected cases of PHP1A even if the classical signs are not present.Keywords
Funding Information
- National Natural Science Foundation of China (81100583, 81670730)
- Natural Science Foundation of Hunan (2016JJ4103)
This publication has 40 references indexed in Scilit:
- Pseudohypoparathyroidism Type 1A-Subclinical Hypothyroidism and Rapid Weight Gain as Early Clinical Signs: A Clinical Review of 10 CasesJournal of Clinical Research in Pediatric Endocrinology, 2016
- GNAS Mutations in Pseudohypoparathyroidism Type 1a and Related DisordersHuman Mutation, 2014
- A Sporadic Case of Pseudohypoparathyroidism Type 1 and Idiopathic Primary Adrenal Insufficiency Associated with a Novel Mutation in the Gnas1 GeneEndocrine Practice, 2014
- A novel mutation in pseudohypoparathyroidism type 1a in a Chinese woman and her son with hypocalcaemiaHong Kong Medical Journal, 2014
- Pseudohypoparathyroidism type 1a and the GNAS p.R231H mutation: Somatic mosaicism in a mother with two affected sonsAmerican Journal of Medical Genetics Part A, 2010
- Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural InsightsMolecular Pharmacology, 2007
- GH secretion in a cohort of children with pseudohypoparathyroidism type IaJournal of Endocrinological Investigation, 2007
- Resistance to Growth Hormone Releasing Hormone and GonadotropinsJournal of Pediatric Endocrinology and Metabolism, 2006
- Two mutations of the Gsα gene in two Japanese patients with sporadic pseudohypoparathyroidism type IaJournal of Human Genetics, 2001
- Conditional activation defect of a human G sα mutantProceedings of the National Academy of Sciences, 1997